Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C11 Methionine PET in Multiple Myeloma
NCT02646085Phase 1Completed
- Start
- Jul 2016
- Primary completion
- Jun 2021
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial. Primary endpoint: Quantitative measure of C11 Methionine uptake at 12 months. Started Jul 2016; status: completed.
Beyond the preview
Go deeper on NCT02646085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02646085.